Omeprazol Hennig (Omeprazole)

Omeprazole blocks the H+/K+‑ATPase enzyme, also known as the gastric proton pump, on the surface of stomach parietal cells. This inhibition stops the final step of acid secretion, leading to a sustained decrease in gastric acidity and allowing damaged tissue to heal.

The dosage of Omeprazol Hennig is determined by the prescribing clinician based on the specific indication, patient age, severity of disease and any relevant comorbidities. The prescriber will set the appropriate strength, frequency and duration of therapy.

Omeprazole is classified as pregnancy category B in many regions, indicating no evidence of risk in animal studies but limited human data. It should be used only if the potential benefit justifies the potential risk to the fetus. Breastfeeding mothers should consult a healthcare professional, as small amounts may be excreted in milk.

To request Omeprazol Hennig, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details and any required import documentation.

Omeprazole belongs to the proton pump inhibitor class, which provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, omeprazole has a well‑established efficacy and safety profile, though individual response and drug‑interaction potential may vary.

Store Omeprazol Hennig tablets at ambient temperature, below 25 °C, in the original packaging. Protect the product from moisture, humidity and direct sunlight to maintain potency throughout its shelf life.

Omeprazol Hennig is taken orally, usually as a whole tablet swallowed with water. It is commonly recommended to take the dose before a meal, often in the morning, but patients should follow the prescribing clinician’s instructions regarding timing and food intake.

Serious adverse reactions, though rare, include severe allergic responses (anaphylaxis), Clostridioides difficile‑associated colitis, low magnesium levels, bone fractures with long‑term use, and acute interstitial nephritis. Patients should seek immediate medical attention if they experience symptoms such as rash, persistent diarrhoea, muscle cramps or unexplained kidney problems.

Individuals with a known hypersensitivity to omeprazole, other proton pump inhibitors, or any excipients in the tablet should avoid the product. Caution is also advised for patients with severe liver disease, and it should be used only under medical supervision in those with significant renal impairment.